| Nov 7 |
Here's Why Bristol-Myers Squibb (NYSE:BMY) Can Manage Its Debt Responsibly
|
| Nov 6 |
Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know
|
| Nov 5 |
Bristol Myers Squibb to Participate in Upcoming Investor Conferences
|
| Nov 4 |
Is Bristol-Myers Squibb Company (BMY) the Best Pharma Stock to Buy Right Now?
|
| Nov 1 |
Bristol Myers Squibb Stock Gets Relative Strength Rating Upgrade
|
| Nov 1 |
Bristol Myers posts long-term Phase 3 data for schizophrenia drug Cobenfy
|
| Nov 1 |
Company News for Nov 1, 2024
|
| Nov 1 |
Bristol-Myers Squibb Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
| Nov 1 |
Bristol-Myers Squibb Co (BMY) Q3 2024 Earnings Call Highlights: Strong Growth and Strategic ...
|
| Nov 1 |
Q3 2024 Bristol-Myers Squibb Co Earnings Call
|
